-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On March 26, the domestic bivalent cervical cancer vaccine started its first dose in Beijing.
1.
1.
To study statistical phenotypes, the younger the person who had sex for the first time, the higher the risk of HPV infection later in their life, especially for women whose first X sex occurred before the age of 15.
2.
HPV can be spread through X intercourse.
3.
Smoking can firstly reduce our body’s immunity and cannot heal itself through our own immune system when infected with HOV; secondly, tobacco itself contains more than 60 carcinogens, which can cause cancer in many tissues of the body.
2.
2.
3.
3.
Public information shows that the bivalent vaccine can prevent HPV 16 and 18 with a high infection rate.
HPV 4-valent vaccine
The 4-valent vaccine can be used to prevent diseases caused by HPV 6, 11, 16, and 18.
HPV 9-valent vaccine
The 9-valent vaccine targets the nine subtypes of HPV, basically including the currently known types of human papillomaviruses, and can prevent and treat nine HPV types 6, 11, 16, 18, 31, 33, 45, 52 and 58.
As long as the three cervical cancer vaccines are vaccinated with the first one and all the injections are completed, more than 70% of HPV infections can be prevented, and there is no need to receive another first cervical cancer vaccine injection.
Leave a message here
